Stock Events

Stock Events

Revenio Group 

$16.41
26
+$0.00+0% Monday 20:00

Statistics

Day High
16.41
Day Low
16.41
52W High
31.47
52W Low
16.41
Volume
1,000
Avg. Volume
32
Mkt Cap
0
P/E Ratio
24.13
Dividend Yield
-
Dividend
-

Upcoming

Dividends

0%Dividend Yield
Apr 25
$0.45
Apr 24
$0.40
Apr 23
$0.39
Apr 22
$0.37
Mar 21
$0.38
10Y Growth
6.42%
5Y Growth
6.07%
3Y Growth
7.15%
1Y Growth
12.25%

Earnings

8SepExpected
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q4 2025
Q1 2026
Next
0.16
0.21
0.26
0.31
Expected EPS
0.2055708
Actual EPS
N/A

Financials

15.87%Profit Margin
Profitable
2020
2021
2022
2023
2024
2025
126.45MRevenue
20.06MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow REVXF. It's not an investment recommendation.
Nordea Bank Abp
6
NDA-FI.HE
Fortum Oyj
5
FORTUM.HE
Apple
4
AAPL
Microsoft
4
MSFT

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Alcon
ALC
Mkt Cap35.89B
Alcon specializes in eye care products, directly competing with Revenio's diagnostic devices and technologies.
Cooper Companies
COO
Mkt Cap14.86B
The Cooper Companies operate in the medical device sector focusing on eye care, providing products that compete with Revenio's offerings.
nVent Electric
NVT
Mkt Cap27.74B
Natus Medical Incorporated offers medical equipment and software for the diagnosis and treatment of disorders and diseases, including those related to eye care.
Staar Surgical
STAA
Mkt Cap1.31B
STAAR Surgical Company specializes in ophthalmic products, directly competing in the eye care market with Revenio.
Johnson & Johnson
JNJ
Mkt Cap627.42B
Johnson & Johnson, through its Vision Care division, competes in the eye health sector, overlapping with Revenio's market.
Novanta
NOVT
Mkt Cap6.3B
Novartis, owning Alcon before its spin-off, remains a competitor through its extensive range of pharmaceuticals and therapies in eye care.
Baxter International
BAX
Mkt Cap13.82B
Baxter International Inc. competes in the healthcare and medical devices sector, including areas that overlap with Revenio's interests.
Boston Scientific
BSX
Mkt Cap75.11B
Boston Scientific Corporation engages in the development of medical devices that could be used in various treatments, including those related to eye care.
Medtronic
MDT
Mkt Cap116.83B
Medtronic plc offers medical technologies, services, and solutions, including those for eye diseases, competing with Revenio's product range.

About

Revenio Group Oyj operates as a healthcare technology company, specializing in the development, production, and global distribution of advanced ophthalmic diagnostic instruments and medical devices. These innovations are engineered to aid in the identification of various eye conditions, including glaucoma, macular degeneration, diabetic retinopathy, and cataracts, serving clientele in Finland, throughout Europe, and worldwide. Its extensive product portfolio includes the iCare IC100 and IC200 tonometers, along with the iCare HOME device for personal eye pressure monitoring. Furthermore, the company provides sophisticated imaging technologies such as the iCare EIDON AF for confocal retinal imaging, DRSplus for screening diabetic retinopathy, the iCare MAIA microperimeter for precise visual field measurements, and iCare COMPASS, which facilitates fundus perimetry using true-color retinal images. Beyond hardware, Revenio also offers Oculo, a comprehensive eye care software platform that seamlessly integrates clinical communication, telehealth functionalities, remote patient monitoring, and robust data analytics. Established in 2001, Revenio Group Oyj is based in Vantaa, Finland.
Show more...
CEO
Mr. Jouni Toijala B.Sc., M.B.A.
Employees
247
Country
Finland
ISIN
FI0009010912
WKN
000805985

Listings

STU
DE
R0V.STU
MU
DE
R0V.MU
HE
FI
REG1V.HE
OTC Link
US
REVXF

0 Comments

Share your thoughts

FAQ

What is Revenio Group stock price today?▼
The current price of REVXF is $16.41 USD — it has increased by +0% in the past 24 hours. Watch Revenio Group stock price performance more closely on the chart.
What is Revenio Group stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on OTC Link exchange Revenio Group stocks are traded under the ticker REVXF.
When is the next Revenio Group earnings date?▼
Revenio Group is going to release the next earnings report on September 08, 2026.
What were Revenio Group earnings last quarter?▼
REVXF earnings for the last quarter are 0.18 USD per share, whereas the estimation was 0.19 USD resulting in a -5.96% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Revenio Group revenue for the last year?▼
Revenio Group revenue for the last year amounts to 126.45M USD.
What is Revenio Group net income for the last year?▼
REVXF net income for the last year is 20.06M USD.
Does Revenio Group pay dividends?▼
Yes, REVXF dividends are paid annual. The last dividend per share was 0.45 USD. As of today, Dividend Yield (FWD)% is 0%.
How many employees does Revenio Group have?▼
As of August 19, 2026, the company has 247 employees.
In which sector is Revenio Group located?▼
Revenio Group operates in the Other sector.
When did Revenio Group complete a stock split?▼
The last stock split for Revenio Group was on March 20, 2020 with a ratio of 2:1.
Where is Revenio Group headquartered?▼
Revenio Group is headquartered in Vantaa, Finland.